09 April 2022 | News
Bharat Biotech has more than 50 million doses of the vaccine readily available
image credit- Bharat Biotech
The price of Bharat Biotech's COVID-19 vaccine COVAXIN has been revised to Rs 225 per dose for private hospitals.
The private hospitals are requested to provide COVAXIN at the revised rate effective 10th April 2022. The price differential with any existing stocks in private hospitals shall be compensated in the form of additional doses.
Fresh stocks of COVAXIN are available and ready for supplies. Bharat Biotech has more than 50 million doses of the vaccine readily available in vials, and over 200 million doses as drug substance. Additional production capacity is also available to meet product demand.
COVAXIN is formulated uniquely such that the same dosage can be administered to adults and children alike. It is a ready-to-use a liquid vaccine, stored at 2-8°C, with 12 months shelf life and multi-dose vial policy. The same vaccine can also be used for 2 dose primary immunization and for booster dose vaccinations.